Modulus Therapeutics is an artificial-intelligence-powered cell therapy design company.
Modulus Therapeutics has raised $3.5M in total funding. The most recent round was Seed. The last funding was announced in July 2021.
Modulus Therapeutics's investors include Madrona, Allen Institute for Artificial Intelligence, KdT Ventures.
Modulus Therapeutics is headquartered in Seattle, United States.
Modulus Therapeutics is an artificial-intelligence-powered cell therapy design company.
Modulus Therapeutics is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Modulus Therapeutics — Funding & Investors." VCBacked, July 15, 2021, https://www.vcbacked.co/company/modulus-therapeutics. Accessed September 29, 2026.
VCBacked. (2021). Modulus Therapeutics — Funding & Investors. Retrieved September 29, 2026, from https://www.vcbacked.co/company/modulus-therapeutics
{{cite web |title=Modulus Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/modulus-therapeutics |website=VCBacked |access-date=September 29, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated